Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination in HCV-Infected Adults Who Are Undergoing Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the fixed-dose combination sofosbuvir/velpatasvir (Epclusa) in adults with hepatitis C undergoing liver transplantation; the trial is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Epclusa (sofosbuvir/velpatasvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2019-02-06